
ALNY Competitors
Alnylam Pharmaceuticals, Inc.
$149.40
-$7.10(-4.54%)
32
Overall
20
Value
27
Tech
50
Quality
Market Cap
$20.01B
Volume
2.52M
52W Range
$149.18 - $479.79
Target Price
$305.74
ALNY competitors: ARWR, REGN, SRPT, OPK, SNY. Alnylam Pharmaceuticals, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ALNY Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals, Inc. | $43.34 | $6.08B | $-4.73 | - | 27 |
| REGN Regeneron Pharmaceuticals, Inc. | $945.63 | $99.08B | $69.09 | 0.39% | 67 |
| SRPT Sarepta Therapeutics, Inc. | $14.64 | $1.58B | $3.27 | - | 47 |
| OPK OPKO Health, Inc. | $1.69 | $1.20B | $-0.20 | - | 55 |
| SNY Sanofi | $47.16 | $115.92B | $5.07 | 5.13% | 76 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $149.40 | -4.5% | 2.52M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW